The Alumni Center team is working remotely.In-person shopping for alumni merchandise in Rochester is temporarily suspended. Shipping for online merchandise orders may be delayed. Thank you for your patience.

Mayo Clinc’s VTE prevention recognized by Centers for Disease Control and Prevention

A Mayo Clinic team was recognized by the Centers for Disease Control and Prevention (CDC) in its Healthcare-associated Venous Thromboembolism Prevention Challenge, or VTE prevention. The efforts of six institutions are covered in a December 2016 supplement to the Journal of Hospital Medicine titled “Preventing Hospital-Acquired Venous Thromboembolism: Lessons from the Field.”

Mayo Clinic’s contribution, “Preventing Acute Care-Associated Venous Thromboembolism in Adult and Pediatric Patients Across a Large Healthcare System,” was authored by Timothy Morgenthaler, M.D. (I ’91, THD ’94), Division of Pulmonary and Critical Care Medicine; and Vilmarie Rodriguez, M.D. (PDHO ’99), Division of Pediatric Hematology-Oncology.

Dr. Rodriguez followed Dr. Morgenthaler’s steps in designing and implementing VTE orders to apply to pediatric patients throughout Mayo’s hospitals. “Prevention of hospital-acquired conditions in hospitalized children is an ongoing priority among many children’s centers, and VTE is one of those complications that can be life-threatening,” she says. “We are in the early stages of enforcing VTE screening and prevention and implementing electronic orders for this purpose. Educating our pediatric trainees and providers is a priority.”

 

Recommended reading

Posts about similar topics: